TSS
ZYNE

Two Sigma Securities’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Two Sigma Securities’s Portfolio ZYNE Stock Details ZYNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-16,367
Closed -$19K – 3256
2022
Q2 		$19K Buy
+16,367
New +$20.8K ﹤0.01% 1971

Other funds holding ZYNE

EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Two Sigma Securities's ZYNE Position: Q3 2022 in Review

Two Sigma Securities sold out of Zynerba Pharmaceuticals, Inc (ZYNE) in Q3 2022, closing a stake of 16,367 shares — an estimated $19K sold.

Two Sigma Securities first reported a position in ZYNE in Q2 2022 and held it in 1 quarter. The position peaked at $19K in Q2 2022. 62 funds tracked by Wall St. Rank hold ZYNE as of Q3 2022.

  • Two Sigma Securities reported no remaining Zynerba Pharmaceuticals, Inc position as of Q3 2022 after selling out during the quarter.
  • Two Sigma Securities sold 16,367 Zynerba Pharmaceuticals, Inc shares in Q3 2022, an estimated $19K.
  • Two Sigma Securities first reported a position in Zynerba Pharmaceuticals, Inc in Q2 2022 and held it in 1 quarter.
  • Two Sigma Securities's Zynerba Pharmaceuticals, Inc position peaked at $19K in Q2 2022.
  • 62 funds tracked by Wall St. Rank held Zynerba Pharmaceuticals, Inc as of Q3 2022.

Based on Two Sigma Securities's 13F filing for Q3 2022, filed 14 Nov 2022.